Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mathias Roth is active.

Publication


Featured researches published by Mathias Roth.


Tissue Engineering Part A | 2015

Engineering of a Secretory Active Three-Dimensional Lacrimal Gland Construct on the Basis of Decellularized Lacrimal Gland Tissue.

Kristina Spaniol; Marco Metzger; Mathias Roth; Burkhard Greve; Sonja Mertsch; Gerd Geerling; Stefan Schrader

Lacrimal gland (LG) insufficiency is a main cause for severe dry eye leading to pain, visual impairment, and eventually loss of sight. Engineering of transplantable LG tissue with secretory capacity is a desirable goal. In this study, a three-dimensional decellularized LG (DC-LG) scaffold with preserved LG morphology was generated by treatment with 1% sodium deoxycholate and DNase solution using porcine LG tissue. To address clinical applicability, the primary in vitro culture of secretory active LG cells from a small tissue biopsy of 1.5 mm diameter was introduced and compared with an established isolation method by enzymatic digestion. Cells from both isolation methods depicted an epithelial phenotype, maintained their secretory capacity for up to 30 days, and exhibited progenitor cell capacity as measured by aldehyde dehydrogenase-1 activity, side population assay, and colony-forming units. Cells from passage 0 were reseeded into the DC-LG and secretory active cells migrated into the tissue. The cells resembled an LG-like morphology and the constructs showed secretory activity. These results demonstrate the possibility of engineering a secretory competent, three-dimensional LG construct using LG cells expanded from a small tissue biopsy and DC-LG as a matrix that provides the native structure and physiological niche for these cells.


Current Eye Research | 2016

Development of Causative Treatment Strategies for Lacrimal Gland Insufficiency by Tissue Engineering and Cell Therapy. Part 1: Regeneration of Lacrimal Gland Tissue: Can We Stimulate Lacrimal Gland Renewal In Vivo?

Jana Dietrich; Isobel Massie; Mathias Roth; Gerd Geerling; Sonja Mertsch; Stefan Schrader

ABSTRACT Severe dry eye syndrome (DES) is a complex disease that is commonly caused by inflammatory and degenerative changes in the lacrimal gland, and can result in severe pain and disruption to visual acuity. In healthy subjects, the ocular surface is continually lubricated by the tear film that ensures that the ocular surface remains moist and free of debris, enabling normal vision. The lacrimal fluid, mid-layer of the tear film, is mainly produced by the lacrimal gland and if this is dysfunctional for any reason, severe DES can develop. Currently, only palliative treatments for DES exist that aim to either replace or retain tears and/or minimize inflammation. A curative approach that aims to trigger the regeneration of existing lacrimal gland tissue in situ may, therefore, be very beneficial to DES patients. This article reviews the different approaches that have been explored toward lacrimal gland regeneration. Progress to date in vitro, in vivo, and in man is described with a focus on clinical feasibility and efficacy. Promising candidates for drug-dependent treatment of DES are growth factors and cytokines, such as hepatocyte growth factor (HGF) and tumor necrosis factor α-stimulated gene 6 protein (TSG-6). Only a few studies have evaluated gene therapy for lacrimal gland deficiencies, but with promising results. However gene therapy carries a variety of risks regarding carcinogenesis and therefore a treatment in the near future using this approach seems to be unlikely. Cell therapies utilizing mesenchymal stem cells (MSCs) seem to be more applicable than those using human amniotic membrane (hAM) epithelial cells or induced pluripotent stem (iPS) cells, since MSCs combine the favorable traits of both (multipotency, capability to stimulate regeneration immunomodulatory and non-immunogenic properties).


Journal of Clinical Microbiology | 2017

Fusarium Keratitis in Germany

Grit Walther; Serena Stasch; Kerstin Kaerger; Axel Hamprecht; Mathias Roth; Oliver A. Cornely; Gerd Geerling; Colin R. MacKenzie; Oliver Kurzai; Marie von Lilienfeld-Toal

ABSTRACT Fusarium keratitis is a destructive eye infection that is difficult to treat and results in poor outcome. In tropical and subtropical areas, the infection is relatively common and associated with trauma or chronic eye diseases. However, in recent years, an increased incidence has been reported in temperate climate regions. At the German National Reference Center, we have observed a steady increase in case numbers since 2014. Here, we present the first German case series of eye infections with Fusarium species. We identified Fusarium isolates from the eye or eye-related material from 22 patients in 2014 and 2015. Thirteen isolates belonged to the Fusarium solani species complex (FSSC), 6 isolates belonged to the Fusarium oxysporum species complex (FOSC), and three isolates belonged to the Fusarium fujikuroi species complex (FFSC). FSSC was isolated in 13 of 15 (85%) definite infections and FOSC in 3 of 4 (75%) definite contaminations. Furthermore, diagnosis from contact lens swabs or a culture of contact lens solution turned out to be highly unreliable. FSSC isolates differed from FOSC and FFSC by a distinctly higher MIC for terbinafine. Outcome was often adverse, with 10 patients requiring keratoplasty or enucleation. The use of natamycin as the most effective agent against keratitis caused by filamentous fungi was rare in Germany, possibly due to restricted availability. Keratitis caused by Fusarium spp. (usually FSSC) appears to be a relevant clinical problem in Germany, with the use of contact lenses as the predominant risk factor. Its outcome is often adverse.


Current Eye Research | 2016

Development of Causative Treatment Strategies for Lacrimal Gland Insufficiency by Tissue Engineering and Cell Therapy. Part 2: Reconstruction of Lacrimal Gland Tissue: What Has Been Achieved So Far and What Are the Remaining Challenges?

Isobel Massie; Jana Dietrich; Mathias Roth; Gerd Geerling; Sonja Mertsch; Stefan Schrader

ABSTRACT The lacrimal gland is located in the upper temporal compartment of the orbita, and along with the ocular surface, eye lids, and sensory and motor nerves forms the lacrimal functional unit (LFU). The LFU is responsible for producing, distributing, and maintaining the tear film in order to maintain a smooth, moist, and regular ocular surface epithelium such that appropriate refractive properties are achieved and the eyeball is protected against dust, debris, and pathogens. If the main lacrimal gland is impaired (due to either disease or injury), this balance is disrupted, and severe quantitative dry eye syndrome (DES) can develop. DES treatments remain palliative, with the most commonly used therapies being based on tear substitution, tear retention, and control of inflammation on the ocular surface. Causative treatments such as salivary gland transplantation have shown to reduce symptoms in very severe cases, however can cause problems on the ocular surface due to different properties of saliva and tears. Therefore, causative approaches for treating DES by regeneration or reconstruction of lacrimal gland tissue depending on disease severity seem highly appealing. This article reviews current approaches for in vitro reconstruction of lacrimal gland tissue. Finally, the limitations that must be overcome before a new, tissue-engineered therapy may be delivered to clinic will be discussed.


Investigative Ophthalmology & Visual Science | 2015

The Influence of Oxygen on the Proliferative Capacity and Differentiation Potential of Lacrimal Gland-Derived Mesenchymal Stem Cells.

Mathias Roth; Kristina Spaniol; Claus Kordes; Silke Schwarz; Sonja Mertsch; Dieter Häussinger; Nicole Rotter; Gerd Geerling; Stefan Schrader

PURPOSE The application of lacrimal gland-derived mesenchymal stem cells (LG-MSC) for the regeneration of lacrimal gland tissue could result in a novel therapy for dry-eye syndrome. To optimize the culture conditions, the purpose of this study was to evaluate the influence of low oxygen on phenotype, differentiation potential, proliferative, and regenerative capacity of murine LG-MSC. METHODS Murine LG-MSC were cultured in 21% and 5% oxygen and characterized by flow cytometry, cell sorter assisted proliferation-, and colony forming unit-assays. Reactive oxygen species (ROS) levels as well as lineage differentiation were evaluated. The effect of conditioned medium of LG-MSC from both oxygen conditions (CM MSC 21%, respectively, CM MSC 5%) on lacrimal gland epithelial cells (LG-EC) was examined in wound healing and proliferation assays. RESULTS Cells under both culture conditions revealed differentiation potential and presented a MSC-specific flow cytometric phenotype. In 5% oxygen, cells yielded less ROS, showed a stable morphology, higher colony forming potential, and an increased proliferation capacity. Five percent oxygen significantly increased the number of CD44+ LG-MSC. Furthermore, CM MSC 5% significantly enhanced migration and proliferation in LG-EC. CONCLUSIONS In vitro expansion in low oxygen preserves the proliferation capacity and differentiation potential of LG-MSC and increases the effects of conditioned medium on migration and proliferation in LG-EC. Therefore, expansion in low oxygen seems to be an excellent method, to obtain vital MSC. Also, an increased number of LG-MSC expressing CD44 was observed under low oxygen, which might be a valuable marker to identify a potent MSC subpopulation.


Klinische Monatsblatter Fur Augenheilkunde | 2014

Clinical diagnostics for the tear film and the ocular surface

Stefan Schrader; David Finis; Kristina Spaniol; Mathias Roth; Philipp Ackermann; Gerd Geerling

OSDI (Ocular Surface Disease Index) und DEQ (Dry Eye Questionnaire). Für klinische Studien empfiehlt sich die Verwendung der etablierten Fragebögen OSDI (Schiffman et al. 2000) oder DEQ (Begley et al. 2002), vor allem aufgrund der guten Quantifizierbarkeit des Schweregrades der Symptome. IDEEL‐Fragebogen (Impact of Dry Eye on Everyday Life questionnaire). Der IDEEL‐Fragebogen scheint allerdings in der Erfassung von Auswirkungen des trockenen Auges auf die Lebensqualität dem OSDI überlegen zu sein (Grubbs et al. 2014).


Experimental Eye Research | 2018

Comparative analysis on the dynamic of lacrimal gland damage and regeneration after Interleukin-1α or duct ligation induced dry eye disease in mice

Jana Dietrich; Carlo Schlegel; Mathias Roth; Joana Witt; Gerd Geerling; Sonja Mertsch; Stefan Schrader

ABSTRACT The loss of functional lacrimal gland (LG) tissue causes quantitative tear deficiency and is the most common reason for the development of severe dry eye disease (DED). The induction of LG regeneration in situ would be a promising approach to curatively treat DED, but underlying mechanisms are mainly unclear. Therefore, this study aims to comparatively evaluate the dynamic of LG damage and regeneration in two mouse models in order to study mechanisms of LG regeneration. Male C57BL/6J mice were used to induce damage to the right extraorbital LG either by a single interleukin (IL) 1&agr; injection or a ligation of the secretory duct for 7 days. Fluorescein staining (FL) and LG wet weight were assessed. In addition, the dynamic of damage and regeneration of acini structures as well as inflammation and the appearance of progenitor cells were (immuno‐) histologically evaluated on day 1, 2, 3, 5, 7 after IL‐1&agr; injection and day 3, 7, 14, 21, 28 after duct ligation (DL). While LG weight was only slightly affected after IL‐1&agr; injection, DL led to a significant decrease at day 7 followed by an increase after re‐opening. Additionally, DL resulted in a more pronounced inflammatory reaction than IL‐1&agr; injection. After DL the infiltration with CD3+ T cells, CD138 + plasma cells and CD68 +macrophages increased, while IL‐1&agr; injection only caused an infiltration with CD68+ macrophages. Furthermore, the damage of LG structures was significantly higher after DL than after IL‐1&agr; injection. Accordingly, regeneration of LG was prolonged and only partial at day 28 after DL, whilst 5 days after IL‐1&agr; injection a complete LG completely regeneration was achieved. We also found a significantly increased number of nestin + mesenchymal stem cells in both models during injury phase. Our results showed that both models induce LG damage followed by a spontaneous regeneration of acini structures. IL‐1&agr; injection caused an immediate inflammation with a transient period of slight tissue damage. However, DL caused a more distinct tissue damage followed by a prolonged period of regeneration, which might make it appear more attractive to study regenerative therapies and their effects on LG regeneration. HIGHLIGHTSTwo mouse models were compared in order to study regenerative therapies.IL‐1&agr; injection caused an immediate inflammation with slight tissue damage.Duct ligation caused marked tissue damage ensued by a partial regeneration period.Duct ligation seems to be the more attractive model to study regenerative therapies.Mesenchymal stem cells appeared to be involved in LG regeneration.


Klinische Monatsblatter Fur Augenheilkunde | 2015

Keratomykose – Therapiestandards und aktuelle Entwicklungen

W. Behrens-Baumann; David Finis; Colin R. MacKenzie; Mathias Roth; Gerd Geerling


Ophthalmologe | 2017

Tintelnotia destructans : Ein neuer Feind vor dem Tore

K. J. Habbe; A. Frings; Stefan Schrader; Mathias Roth; C. MacKenzie; G. Walther; O. Kurzai; Gerd Geerling


Klinische Monatsblatter Fur Augenheilkunde | 2017

Periokuläre nekrotisierende Fasziitis – Fallbericht und Überblick

Mathias Roth; Christoph Holtmann; N. Kajasi; R. S. Lanzman; Colin R. MacKenzie; Gerd Geerling; Maria Borrelli

Collaboration


Dive into the Mathias Roth's collaboration.

Top Co-Authors

Avatar

Gerd Geerling

University of Düsseldorf

View shared research outputs
Top Co-Authors

Avatar

Stefan Schrader

University of Düsseldorf

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sonja Mertsch

University of Düsseldorf

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David Finis

University of Düsseldorf

View shared research outputs
Top Co-Authors

Avatar

Jana Dietrich

University of Düsseldorf

View shared research outputs
Top Co-Authors

Avatar

M Brachert

University of Düsseldorf

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge